Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,283
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for
Prostate Cancer Metastatic
Location: Aurora CO, Highlands Ranch CO, Lone Tree CO, Pierre SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136624
Phase 3, Recruiting
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT07030283
Phase 1, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
for
Neoplasms
Location: Aurora CO, Duarte CA, San Antonio TX, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06884618
Phase 1, Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Aurora CO, Lincoln NE, Chandler AZ, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Aurora CO, Salt Lake City UT, Tucson AZ, Dallas TX,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Aurora CO, Sioux Falls SD, St Louis MO, Memphis TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase 1, Phase 2, Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Aurora CO, St Louis MO, Duarte CA, Houston TX,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Aurora CO, Oklahoma City OK, Irving TX, Orange CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase 1, Phase 2, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: Colorado Springs CO, California City CA, Texas City TX,
Location: Aurora CO, Oklahoma City OK, Boston MA, Weymouth MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06366347
Phase 2, Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Aurora CO, Los Angeles CA, Newport Beach CA,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Aurora CO, West Valley City UT, Oklahoma City OK,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Aurora CO, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Aurora CO, Omaha NE, Tucson AZ, Spokane WA, Peoria IL,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Specimen Banking From Patients With Lung Cancer
for
Lung Neoplasms
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT01585675
Recruiting
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Aurora CO, Dallas TX, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Aurora CO, Tulsa OK, Las Vegas NV, Tucson AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer
Location: Aurora CO, Phoenix AZ, Rochester MN, Iowa City IA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06892548
Phase 1, Phase 2, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Aurora CO, Lakewood CO, Greenwood Village CO,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase 3, Recruiting
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor